▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4090 by analyst upside · 2026-11-12
DOCS
Doximity, Inc.
Healthcare · Market Cap $6B · P/E 46.1x
ANALYST PRICE TARGET
-6.0%
implied upside to consensus target
Current Price $33.22
Consensus Target $31.22
Bull Target $41.0
Bear Target $18.0
Analysts Covering 18
ANALYST CONSENSUS - BUY
Strong Buy
4
Buy
3
Hold
9
Sell
2
52-Week Low $17.15
52-Week High $53.46
YTD Return -23.3%
FUNDAMENTALS
Market Cap $6B
P/E Ratio (TTM) 46.1x
Forward P/E 21.4x
EPS (TTM) $0.72
PEG Ratio 0.59
Dividend Yield N/A
Revenue (TTM) $662M
Profit Margin 21.1%
52-WEEK RANGE
52-Week Low $17.15
52-Week High $53.46
Current Price $33.22
Bear Target $18.0
Bull Target $41.0
● Now $33.22 ● Target $31.22
TRADING DATA
Avg Volume 3.0M
YTD Return -23.3%
Analyst Count 18
Consensus Buy
Upside to Target -6.0%
Last Updated 2026-11-12

ANALYST SUMMARY

Doximity, Inc. (DOCS) is currently trading at $33.22 with a Wall Street consensus price target of $31.22, which is 6.0% below the current price over the next 12 months. 18 analysts currently cover DOCS, with a consensus rating of Buy - 39% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $41.0, while the most cautious has a target of $18.0.

DOCS operates in the Healthcare sector with a market capitalisation of $6B. The stock is down 23.3% year-to-date and is currently trading near the lower end of its 52-week range of $17.15 – $53.46.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

LIVN +15.5%
LivaNova PLC
$5B · P/E 26.1x · Buy
TFX +7.5%
Teleflex Incorporated
$6B · P/E 76.6x · Buy
PACS +22.5%
PACS Group, Inc.
$8B · P/E 28.0x · Buy
HQY +17.1%
HealthEquity, Inc.
$9B · P/E 37.2x · Buy
GRFS +17.3%
Grifols, S.A.
$6B · P/E 10.7x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for DOCS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-11-06 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-11-06 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-11-06 Building track record
Needham reit
Buy → Buy 2026-11-06 20% win rate (5 calls)
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-09-29 Building track record
Freedom Capital Markets ↓ Downgrade
Buy → Hold 2026-09-08 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-08-21 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-08-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
22/30
Consensus clarity
16/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →